New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
16:36 EDTBAXBaxter announces recall of parenteral nutrition products
Baxter announced it has initiated a voluntary recall in the United States of two lots of Clinimix and one lot of Clinimix E Injection parenteral nutrition products to the user level due to complaints of particulate matter found in the products. If infused, particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney or liver, the company said. There is also the possibility of allergic reactions, local irritation, and inflammation in tissues and organs, Baxter added. "There have been no reported adverse events associated with this issue to date, and the root cause of this voluntary recall has been identified and resolved," it stated. The recall is being conducted with the knowledge of the FDA.
News For BAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 16, 2015
06:11 EDTBAXBaxter resumed with a Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Brooks West downgraded Baxter (BAX) to Neutral after resuming coverage of the name. The company, post the spin of Baxalta (BXLT), "has a number of moving pieces that need to be addressed," West tells investors in a research note. He lowered his price target for shares to $39 from $90.
November 13, 2015
17:04 EDTBAXThird Point gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use